EmrE, a small Escherichia coli multidrug transporter, protects Saccharomyces cerevisiae from toxins by sequestration in the vacuole

Journal of Bacteriology

Volumn 181, Issue 3, 1999, Pages 949-956

  Yelin, Rodrigo ^a   Rotem, Dvir ^a   Schuldiner, Shimon ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CARRIER PROTEIN; TOXIN;

ARTICLE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ESCHERICHIA COLI; GENE EXPRESSION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SACCHAROMYCES CEREVISIAE;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; SACCHAROMYCES CEREVISIAE;

EID: 0032891452     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.181.3.949-956.1999     Document Type: Article

References (47)

1. Alani, E., L. Cao, and N. Kleckner. 1987. A method for gene disruption that allows repeated use of URA3 selection in the construction of multiply disrupted yeast strains. Genetics 116:541-545.
2. Arkin, I., W. Russ, M. Lebendiker, and S. Schuldiner. 1996. Determining the secondary structure and orientation of EmrE, a multi-drug transporter, indicates a transmembrane four helix burdle. Biochemistry 35:7233-7238.
3. Benderra, Z., H. Morjani, A. Trussardi, and M. Manfait. 1998. Role of the vacuolar H+-ATPase in daunorubicin distribution in etoposide-resistant MCF7 cells overexpressing the multidrug-resistance associated protein. Int. J. Oncol. 12:711-715.
4. Bennetzen, J. L., and B. D. Hall. 1982. Codon selection in yeast. J. Biol. Chem. 257:3026-3031.
5. Bobichon, H., M. Colin, C. Depierreux, F. Liautaud-Roger, and J. C. Jardillier. 1996. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drue exclusion. J. Exp. Ther. Oncol. 1:49-61.
6. Breuninger, L. M., S. Paul, K. Gaughan, T. Miki, A. Chan, S. A. Aarnnson, and G. D. Kruh. 1995. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 55:5342-5347.
7. Cleary, I., G. Doherty, E. Moran, and M, Clynes. 1997. The multidrugresistant human lung tumour cell line. DLKP-A10. expresses novel drug accumulation and sequestration systems. Biochem. Pharmacol. 53:1493-1502.
8. Conklin, D. S., M. R. Culbertson, and C. Kung. 1994. Interactions between gene products involved in divalent cation transport in Saccharomyces cerevisiae. Mol. Gen. Genet. 244:303-311.
9. Ehrenhofer-Murray, A. E., M. U. Seitz, and C. Sengstag. 1998. The Sge1 protein of Saccharomyces cerevisiae is a membrane-associated multidrug transporter. Yeast 14:49-65.
10. Ehrenhofer-Murray, A. E., F. E. Wurgler, and C. Sengstag. 1994. The Saccharomyces cerevisiae SGE1 gene product: a novel drug-resistance protein within the major facilitator superfamily. Mol. Gen. Genet. 244:287-294.
11. Elble, R. 1992. A simple and efficient procedure for transformation of yeasts. BioTechniques 13:18-20.
12. Franzusoff, A. J., and V. P. Cirillo. 1983. Glucose transport activity in isolated plasma membrane vesicles from Saccharomyces cerevisiae. J. Biol. Chem. 258:3608-3614.
13. Gharieb, M. M., and G. M. Gadd. 1998. Evidence for the involvement of vacuolar activity in metal(loid) tolerance: vacuolar-lacking and -defective mutants of Saccharomyces cerevisiae display higher sensitivity to chromate, tellurite and selenite. Biometals 11:101-106.
14. Greenfield, N. J., M. Hussain, and J. Lenard. 1987. Effects of growth state and amines on cytoplasmic and vacuolar pH, phosphate and polyphosphate levels in Saccharomyces cerevisiae: a 31P-nuclear magnetic resonance study. Biochim. Biophys. Acta 926:205-214.
15. Grinius, L., G. Dreguniene, E. B. Goldberg, C. H. Liao, and S. J. Projan. 1992. A staphylococcal multidrug resistance gene product is a member of a new protein family. Plasmid 27:119-129.
16. Guthrie, C., and G. R. Fink (ed.). 1991. Methods in Enzymology, vol. 194. Academic Press, San Diego, Calif.
17. Hanahan, D. 1983. Studies on transformation of Escherichia coli with plasmids. J. Mol. Biol. 166:557-580.
18. Heim, R., A. B. Cubitt, and R. Y. Tsien. 1995. Improved green fluorescence. Nature 373:663-664.
19. Joho, M., Y. Ishikawa, M. Kunikane, M. Inouhe, H. Tohoyama, and T. Murayama. 1992. The subcellular distribution of nickel in Ni-sensitive and Ni-resistant strains of Saccharomyces cerevisiae. Microbios 71:149-159.
20. Kane, P. M., M. C. Kuehn, I. Howald-Stevenson, and T. H. Stevens. 1992. Assembly and targeting of peripheral and integral membrane subunits of the yeast vacuolar H(+)-ATPase. J. Biol. Chem. 267:447-454.
21. Kitamoto, K., K. Yoshizawa, Y. Ohsumi, and Y. Anraku. 1988. Dynamic aspects of vacuolar and cytosolic amino acid pools of Saccharomyces cerevisiae. J. Bacteriol. 170:2683-2686.
22. Klionsky, D. J. 1998. Nonclassical protein sorting to the yeast vacuole. J. Biol. Chem. 273:10807-10810.
23. Li, Z. S., Y. P. Lu, R. G. Zhen, M. Szczypka, D. J. Thiele, and P. A. Rea. 1997. A new pathway for vacuolar cadmium sequestration in Saccharomyces cerevisiae: YCF1-catalyzed transport of bis(glutathionato)cadmium. Proc. Natl. Acad. Sci. USA 94:42-17.
24. Licht, T., F. Hermann, M. M. Gottesman, and I. Pastan. 1997. In vivo drug-selectable genes: a new concept in gene therapy. Stem Cells 15:104-111.
25. Liu, Y., D. Peter, A. Koghani, S. Schuldiner, G. Prive, D. Eisenberg, N. Brecha, and R. Edwards. 1992. A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter. Cell 70:539-551.
26. Morimyo, M., E. Kongo, H. Hama-Inaba, and I. Machida. 1992. Cloning and characterization of the mvrC gene of Escherichia coli K12 which confers resistance against methyl viologen toxicity. Nucleic Acids Res. 20:3159-3165.
27. Ohsumi, Y., K. Kitamoto, and Y. Anraku. 1988. Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion. J. Bacteriol. 170:2676-2682.
28. Prasher, D. C., V. K. Eckenrode, W. W. Ward, F. G. Prendergast, and M. J. Cormier. 1992. Primary structure of the Aequorea victoria green-fluorescent protein. Gene 111:229-233.
29. Purewal, A. S., I. G. Jones, and M. Midgley. 1990. Cloning of the ethidium efflux gene from Escherichia coli. FEMS Microbiol. Lett. 68:73-76.
30. Ramsay, L. M., and G. M. Gadd. 1997. Mutants of Saccharomyces cerevisiae defective in vacuolar function confirm a role for the vacuole in toxic metal ion detoxification. FEMS Microbiol. Lett. 152:293-298.
31. Ramsay, R. R., M. J. Krueger, S. K. Youngster, and T. P. Singer. 1991. Evidence that the inhibition sites of the neurotoxic amine 1-methyl-4-phenylpyridinium (MPP +) and of the respiratory chain inhibitor piericidin A are the same. Biochem. J. 273:481-484.
32. Sato, T., Y. Ohsumi, and Y. Anraku. 1984. Substrate specificities of active transport systems for amino acids in vacuolar-membrane vesicles of Saccharomyces cerevisiae. Evidence of seven independent proton/amino acid antiport systems. J. Biol. Chem. 259:11505-11508.
33. Schagger, H., and G. von Jagow. 1987. Tricine-SDS PAGE for the separation of proteins in the range from 1 to 100 kDa. Anal. Biochem. 166:368-379.
34. Schuldiner, S., M. Lebendiker, and H. Yerushalmi. 1997. EmrE, the smallest ion coupled transporter, provides a unique paradigm for structure function studies. J. Exp. Biol. 200:335-341.
35. Shapiro, A. B., K. Fox, P. Lee, Y. D. Yang, and V. Ling. 1998. Functional intracellular P-glycoprotein. Int. J. Cancer 76:857-864.
36. Szczypka, M. S., Z. Zhu, P. Silar, and D. J. Thiele. 1997. Saccharomyces cerevisiae mutants altered in vacuole function are defective in copper detoxification and iron-responsive gene transcription. Yeast 13:1423-1435.
37. Tuite, M. F., M. J. Dobson, N. A. Roberts, R. M. King, D. C. Burke, S. M. Kingsman, and A. J. Kingsman. 1982. Regulated high efficiency expression of human interferon-alpha in Saccharomyces cerevisiae. EMBO J. 1:603-608.
38. Tyers, M., G. Tokiwa, R. Nash, and B. Futcher. 1992. The Cln3-Cdc28 kinase complex of S. cerevisiae is regulated by proteolysis and phosphorylation. EMBO J. 11:1773-1784.
39. Vandenbol, M., J. C. Jauniaux, and M. Grenson. 1989. Nucleotide sequence of the Saccharomyces cerevisiae PUT4 proline-permease-encoding gene: similarities between CAN1. HIP1 and PUT4 permeases. Gene 83:153-159.
40. Vida, T. A., and S. D. Emr. 1995. A new vital stain for visualizing vacuolar membrane dynamics and endocytosis in yeast. J. Cell Biol. 128:779-792.
41. Wilson, I. A., H. L. Niman, R. A. Houghten, A. R. Cherenson, M. L. Connolly, and R. A. Lerner. 1984. The structure of an antigenic determinant in a protein. Cell 37:767-778.
42. Wink, M. 1993. The plant vacuole: a multifunctional compartment. J. Exp. Bot. 44:231-246.
43. Yanisch-Perron, C., J. Vieira, and J. Messing. 1985. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 33:103-199.
44. Yelin, R., and S. Schuldiner. 1995. The pharmacological profile of the vesicular monoamine transporter resembles that of multidrug transporters. FEBS Lett. 377:201-207.
45. + and is soluble in organic solvents. J. Biol. Chem. 270:6856-6863.
46. Yerushalmi, H., M. Lebendiker, and S. Schuldiner. 1996. Negative dominance studies demonstrate the oligomeric structure of EmrE, a multidrug antiporter from Escherichia coli. J. Biol. Chem. 271:31044-31048.
47. Zenk, M. H. 1996. Heavy metal detoxification in higher plants - a review. Gene 179:21-30.